Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Identify which tilts (such as value or quality) tend to be more tax-efficient in retirement index funds and how these choices affect after-tax performance and risk.
24,606 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...
UiPath edges higher as investors monitor its agentic automation strategy ahead of earnings. This analysis breaks down...
A landmark portfolio reshuffle puts Alphabet ahead of Berkshire's long-time Coca-Cola cornerstone. This analysis expl...
Elon Musk and Sam Altman trade public jabs over who should lead the AI investment story. The clash is fueling investo...
A delayed earnings release and a premium acquisition sparked a slide in Valaris shares. This article breaks down what...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
When a pop star challenges a political use of her music, the ripple effects reach far beyond headlines. This analysis...
Robotics stocks soar tuesday as OUST and TER led a broad move higher on AI demand and automation optimism. Strong Q4 ...
Investing in Coca-Cola offers more than a familiar brand. This guide breaks down the five-year outlook, key drivers, ...
Middleby Corp. launches its most sweeping restructuring in years, slimming the portfolio to focus on core, higher-mar...
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...